...
机译:类风湿性关节炎围手术期中断4周的tocilizumab治疗的类风湿关节炎患者联合手术后C反应蛋白水平和发热趋势的分析
Department of Orthopaedic Surgery, Institute of Rheumatology, Tokyo Women’s Medical University, 10-22 Kawada, Shinjuku, Tokyo, 162-0054, Japan;
Department of Orthopaedic Surgery, Institute of Rheumatology, Tokyo Women’s Medical University, 10-22 Kawada, Shinjuku, Tokyo, 162-0054, Japan;
Department of Orthopaedic Surgery, Institute of Rheumatology, Tokyo Women’s Medical University, 10-22 Kawada, Shinjuku, Tokyo, 162-0054, Japan;
Department of Orthopaedic Surgery, Institute of Rheumatology, Tokyo Women’s Medical University, 10-22 Kawada, Shinjuku, Tokyo, 162-0054, Japan;
Department of Orthopaedic Surgery, Institute of Rheumatology, Tokyo Women’s Medical University, 10-22 Kawada, Shinjuku, Tokyo, 162-0054, Japan;
Department of Orthopaedic Surgery, Institute of Rheumatology, Tokyo Women’s Medical University, 10-22 Kawada, Shinjuku, Tokyo, 162-0054, Japan;
Department of Orthopaedic Surgery, Ins;
Anti IL-6 receptor blocker; C-reactive protein; Orthopedic joint surgery; Rheumatoid arthritis; Tocilizumab;
机译:类风湿性关节炎患者接受围手术期4周中断的tocilizumab联合手术后C反应蛋白水平和发热趋势的分析。
机译:在真实环境中接受类风湿关节炎治疗的类风湿性关节炎患者在骨科手术后的围手术期临床特征和并发症的分析:围手术期(TOPP)多中心TOcilizumab研究的结果
机译:托珠单抗治疗的类风湿关节炎患者关节手术后的实验室和发热特征。
机译:类风湿性关节炎患者膝关节变化分析的仪表:重点是低频振动
机译:抵抗训练对接受线虫治疗的类风湿关节炎患者胰岛素敏感性和炎症标志物的影响。
机译:扩展报告:接受托珠单抗治疗的类风湿关节炎患者关节手术后的实验室和发热特征
机译:托珠单抗治疗的类风湿关节炎患者关节手术后的实验室和发热特征